1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Aspire Allergy & Sinus

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2012

Location

Austin TX US

Primary Industry

Healthcare Specialists

About

Founded in 2012 and based in Texas, US, Aspire Allergy & Sinus operates as a provider of allergy and sinus therapies including, allergy shots, immunotherapy treatment for environmental and food allergies.
Current Investors
Source Capital, Harvey & Company

Request a demo to show more

Primary Industry
Healthcare Specialists
Sub Industries
Healthcare Specialists
Website
www.aspireallergy.com
Verticals
FinTech
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only

Deals

Deals Type
Growth
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Aspire Allergy & Sinus 27 Jul 2018
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.